aap Implantate AG
aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight plates, knee, elbow, wrist, and shoulder. It also provides hole screws and Repro Bone materials. The company sells its products directly to hospitals, purchasing groups, and hospital… Read more
aap Implantate AG (AAQ1) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2022: -0.052x
Based on the latest financial reports, aap Implantate AG (AAQ1) has a cash flow conversion efficiency ratio of -0.052x as of June 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-659.50K) by net assets (€12.63 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
aap Implantate AG - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how aap Implantate AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
aap Implantate AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of aap Implantate AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PCC Exol SA
WAR:PCX
|
0.056x |
|
SLP Resources Bhd
KLSE:7248
|
-0.007x |
|
Live Ventures Inc
NASDAQ:LIVE
|
0.103x |
|
Pinnacle Silver and Gold Corp.
V:PINN
|
N/A |
|
Yw Company Limited
KQ:051390
|
0.072x |
|
Avonmore Capital & Management Services Limited
NSE:AVONMORE
|
0.003x |
|
Eureka Design Public Company Limited
BK:UREKA
|
0.002x |
|
Airthings ASA
PINK:ARTGF
|
-0.038x |
Annual Cash Flow Conversion Efficiency for aap Implantate AG (2016–2024)
The table below shows the annual cash flow conversion efficiency of aap Implantate AG from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €10.46 Million | €-1.12 Million | -0.107x | +70.14% |
| 2023-12-31 | €8.10 Million | €-2.92 Million | -0.360x | -143.82% |
| 2022-12-31 | €12.83 Million | €-1.89 Million | -0.148x | +23.67% |
| 2021-12-31 | €12.78 Million | €-2.47 Million | -0.193x | +45.86% |
| 2020-12-31 | €10.29 Million | €-3.67 Million | -0.357x | -16.83% |
| 2019-12-31 | €18.87 Million | €-5.77 Million | -0.306x | -80.31% |
| 2018-12-31 | €34.92 Million | €-5.92 Million | -0.170x | -32.90% |
| 2017-12-31 | €42.56 Million | €-5.43 Million | -0.128x | +3.01% |
| 2016-12-31 | €54.78 Million | €-7.20 Million | -0.131x | -- |